Guntram Schernthaner

Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

John Dormandy, B Charbonnel, D.J.A. Eckland et al. · The Lancet · 2005 · 4.1K citations · Full text

Diabetes Management, Cardiovascular Disease, Health Policy +10

Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study

John B. Buse, Michael A. Nauck, Thomas Först et al. · The Lancet · 2012 · 559 citations

Diabetes Management, Diabetes, Type 2 +5

Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke

Robert Wilcox, Marie‐Germaine Bousser, D. J. Betteridge et al. · Stroke · 2007 · 473 citations

Canagliflozin Compared With Sitagliptin for Patients With Type 2 Diabetes Who Do Not Have Adequate Glycemic Control With Metformin Plus Sulfonylurea

Guntram Schernthaner, Jorge Luiz Gross, Julio Rosenstock et al. · Diabetes Care · 2013 · 473 citations · Full text

Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population

J. Floege, Jae Bum Kim, Elizabeth Ireland et al. · Nephrology Dialysis Transplantation · 2010 · 468 citations · Full text